首页 | 官方网站   微博 | 高级检索  
     

绞股蓝治疗糖尿病的效应成分群及作用机制研究进展
引用本文:诸夔妞,寿旗扬,田雨闪,谷贵章,胡奇杰,杨红霞,陈晓平,王新财.绞股蓝治疗糖尿病的效应成分群及作用机制研究进展[J].中草药,2020,51(8):2248-2257.
作者姓名:诸夔妞  寿旗扬  田雨闪  谷贵章  胡奇杰  杨红霞  陈晓平  王新财
作者单位:湖州市食品药品检验研究院, 浙江 湖州 313000;浙江中医药大学第二临床医学院, 浙江 杭州 310053;中国药科大学 江苏省中药评价与转化重点实验室, 江苏南京 211198
基金项目:国家自然科学基金资助项目(81873047);湖州市公益性技术应用研究重点项目(2018GZ03)
摘    要:糖尿病是一种以慢性高血糖为主要特征的代谢性疾病。绞股蓝Gynostemma pentaphyllum作为传统的药食两用中药品种之一,具有多种药理活性。近年来,绞股蓝在治疗糖尿病方面的研究取得了较大进展,其作用机制的研究也日趋深入。对2004年以来绞股蓝及绞股蓝皂苷、多糖、粗提物等效应成分群治疗糖尿病的药理作用,以及绞股蓝抑制糖苷酶活性、改善胰岛素抵抗、调节糖脂代谢、调节肠道菌群、抗氧化等几种可能的作用机制进行了综述,以期为绞股蓝治疗糖尿病的活性成分及分子机制的进一步研究和绞股蓝的开发和应用提供参考。

关 键 词:绞股蓝  效应成分群  糖尿病  降血糖  作用机制
收稿时间:2019/11/12 0:00:00

Research progress on bioactive component groups and mechanisms of Gynostemma pentaphyllum for treatment of diabetes
ZHU Kui-niu,SHOU Qi-yang,TIAN Yu-shan,GU Gui-zhang,HU Qi-jie,YANG Hong-xi,CHEN Xiao-ping,WANG Xin-cai.Research progress on bioactive component groups and mechanisms of Gynostemma pentaphyllum for treatment of diabetes[J].Chinese Traditional and Herbal Drugs,2020,51(8):2248-2257.
Authors:ZHU Kui-niu  SHOU Qi-yang  TIAN Yu-shan  GU Gui-zhang  HU Qi-jie  YANG Hong-xi  CHEN Xiao-ping  WANG Xin-cai
Affiliation:Huzhou Institute for Food and Drug Control, Huzhou 313000, China;The 2nd Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou 310053, China;Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China
Abstract:Diabetes mellitus is a systemic metabolic disease characterized by chronic hyperglycemia. Gynostemma pentaphyllum served as one of the traditional Chinese medicinal and edible herbs has a variety of pharmacological properties. In recent years, great progress has been achieved on the treatment of diabetes, and the research on its potential mechanisms are gradually deepened. In this study, the antidiabetic effects of G. pentaphyllum and the bioactive component groups including gypenosides, polysaccharides and crude extracts, and the possible molecular mechanisms, such as inhibiting glycosidase activity, improving insulin resistance, anti-oxidation, regulating glycolipid metabolism and gut microbiota, were summarized from 2004 to 2019. This review provides the guidance for the further study on the active components and molecular mechanisms in treating diabetes, and the reference for the development and application of G. pentaphyllum.
Keywords:Gynostemma pentaphyllum (Thunb  ) Makino  bioactive component groups  diabetes  hypoglycemic effect  mechanisms
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号